lumbar disc herniation
Conditions
Interventions
Western medicine control group:Give oral Celecoxib capsules twice a day, one tablet (0.2g) at a time. Methylcobalamin tablets are administered three times a day, one tablet (0.5mg) at a time, continuo
Chinese medicine control group:Give Ganjiang Lingzhu Decoction, one dose per day, decoct twice in water to 300ml, take 150ml separately in the morning and evening, and continuously administer for 21 d
Experiment group:Give Xuanbi Jianyao Decoction an additional or reduced dose per day decoct twice in water to 300ml and take 150ml separately in the morning and evening for 21 consecutive days.
Sponsors
Guangdong Provincial Hospital of Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. Meet the diagnostic criteria for lumbar disc herniation; 2. Those who meet the classification of traditional Chinese medicine cold dampness obstruction type; 3. Between the ages of 18 and 80; 4. The VAS score is between 3 and 7 points; 5. Those who can complete various examinations and scoring scales according to the doctor's requirements; 6. Those who have not used any other drugs or treatment plans within the past two weeks and have no allergies to the drugs involved in this study; 7. Patients who voluntarily participate in the experimental study and cooperate with the completion of the course of treatment.
Exclusion criteria
Exclusion criteria: 1. The patients who are allergic to the drugs used in the study or cannot independently complete this study; 2. The patients with severe osteoporosis lumbar spinal stenosis lumbar tuberculosis lumbar spondylolisthesis and clear surgical indications; 3. Severe liver kidney heart brain and other functional impairments; 4. Women of childbearing age and lactating women who are pregnant or preparing for pregnancy within six months; 5. Other research drugs are being used; 6. Patients with previous peptic ulcer disease or sulfonamide allergy.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Overall efficacy evaluation;VAS score; | — |
Secondary
| Measure | Time frame |
|---|---|
| Traditional Chinese Medicine Syndrome Points;ODI score;Improved JOA score; | — |
Countries
China
Contacts
Public ContactChen Bolai
Guangdong Provincial Hospital of Chinese Medicine
Outcome results
None listed